“Co-supplementation of oral antioxidant to PUVASol therapy has no effect on oxidative stress index in patients of unstable vitiligo: A hospital based pilot study”, J Pak Assoc Dermatol, vol. 30, no. 1, pp. 13–20, Aug. 2020, doi: 10.66344/jpad.v30i1.1378.